$PRNB Principia Biopharma Inc. Insider Trading Week 37/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Principia Biopharma Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Principia Biopharma Inc. in week 37/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 167,537 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 453,954 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 521,235 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Option Exercise | C | 0.00 | 625,482 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | P | 17.00 | 270,000 | 4,590,000 | 2,038,208 | 1.8 M to 2 M (+15.27 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | C | 0.00 | 167,537 | 0 | 1,768,208 | 1.6 M to 1.8 M (+10.47 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | C | 0.00 | 453,954 | 0 | 1,600,671 | 1.1 M to 1.6 M (+39.59 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | C | 0.00 | 521,235 | 0 | 1,146,717 | 625.5 K to 1.1 M (+83.33 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Sofinnova Venture Partners VII ... | 10% Owner | Buy | C | 0.00 | 625,482 | 0 | 625,482 | 0 to 625.5 K |
| Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 167,537 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 544,047 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 260,617 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 312,741 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,070,771 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 250,000 | 4,250,000 | 2,605,713 | 2.4 M to 2.6 M (+10.61 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 167,537 | 0 | 2,355,713 | 2.2 M to 2.4 M (+7.66 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 544,047 | 0 | 2,188,176 | 1.6 M to 2.2 M (+33.09 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 260,617 | 0 | 1,644,129 | 1.4 M to 1.6 M (+18.84 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 312,741 | 0 | 1,383,512 | 1.1 M to 1.4 M (+29.21 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,070,771 | 0 | 1,070,771 | 0 to 1.1 M |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | C | 0.00 | 167,537 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | C | 0.00 | 544,047 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | C | 0.00 | 260,617 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | C | 0.00 | 312,741 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Option Exercise | C | 0.00 | 1,070,771 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Buy | P | 17.00 | 270,000 | 4,590,000 | 437,537 | 167.5 K to 437.5 K (+161.16 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Buy | C | 0.00 | 167,537 | 0 | 167,537 | 0 to 167.5 K |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Buy | C | 0.00 | 544,047 | 0 | 2,188,176 | 1.6 M to 2.2 M (+33.09 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Buy | C | 0.00 | 260,617 | 0 | 1,644,129 | 1.4 M to 1.6 M (+18.84 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Buy | C | 0.00 | 312,741 | 0 | 1,383,512 | 1.1 M to 1.4 M (+29.21 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Becker Daniel J. | Director | Buy | C | 0.00 | 1,070,771 | 0 | 1,070,771 | 0 to 1.1 M |
| Sep 20 2018 | PRNB | Principia Biopharm ... | New Leaf Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 167,537 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | New Leaf Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 544,047 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | New Leaf Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 260,617 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | New Leaf Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 312,741 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | New Leaf Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,070,771 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | New Leaf Ventures II, L.P. | 10% Owner | Buy | P | 17.00 | 270,000 | 4,590,000 | 437,537 | 167.5 K to 437.5 K (+161.16 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | New Leaf Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 167,537 | 0 | 167,537 | 0 to 167.5 K |
| Sep 20 2018 | PRNB | Principia Biopharm ... | New Leaf Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 544,047 | 0 | 2,188,176 | 1.6 M to 2.2 M (+33.09 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | New Leaf Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 260,617 | 0 | 1,644,129 | 1.4 M to 1.6 M (+18.84 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | New Leaf Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 312,741 | 0 | 1,383,512 | 1.1 M to 1.4 M (+29.21 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | New Leaf Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 1,070,771 | 0 | 1,070,771 | 0 to 1.1 M |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | C | 0.00 | 167,537 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | C | 0.00 | 544,047 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | C | 0.00 | 260,617 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | C | 0.00 | 312,741 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Option Exercise | C | 0.00 | 1,070,771 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | P | 17.00 | 270,000 | 4,590,000 | 2,625,713 | 2.4 M to 2.6 M (+11.46 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | C | 0.00 | 167,537 | 0 | 2,355,713 | 2.2 M to 2.4 M (+7.66 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | C | 0.00 | 544,047 | 0 | 2,188,176 | 1.6 M to 2.2 M (+33.09 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | C | 0.00 | 260,617 | 0 | 1,644,129 | 1.4 M to 1.6 M (+18.84 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | C | 0.00 | 312,741 | 0 | 1,383,512 | 1.1 M to 1.4 M (+29.21 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | George Simeon | Director | Buy | C | 0.00 | 1,070,771 | 0 | 1,070,771 | 0 to 1.1 M |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Gourlay Steve | Chief Medical Offic ... | Option Exercise | C | 0.00 | 7,269 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Gourlay Steve | Chief Medical Offic ... | Buy | C | 0.00 | 7,269 | 0 | 107,857 | 100.6 K to 107.9 K (+7.23 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Option Exercise | C | 0.00 | 240 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Option Exercise | C | 0.00 | 240 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Option Exercise | C | 0.00 | 240 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Option Exercise | C | 0.00 | 988 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Option Exercise | C | 0.00 | 988 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Option Exercise | C | 0.00 | 988 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Buy | C | 0.00 | 240 | 0 | 6,732 | 6.5 K to 6.7 K (+3.70 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Buy | C | 0.00 | 988 | 0 | 6,492 | 5.5 K to 6.5 K (+17.95 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Buy | C | 0.00 | 240 | 0 | 6,732 | 6.5 K to 6.7 K (+3.70 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Buy | C | 0.00 | 988 | 0 | 6,492 | 5.5 K to 6.5 K (+17.95 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Buy | C | 0.00 | 240 | 0 | 6,732 | 6.5 K to 6.7 K (+3.70 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | Babler Martin | Chief Executive Off ... | Buy | C | 0.00 | 988 | 0 | 6,492 | 5.5 K to 6.5 K (+17.95 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 1,521,895 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 4,942,070 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 2,367,424 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 2,840,909 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 9,726,783 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 17.00 | 270,000 | 4,590,000 | 2,625,713 | 2.4 M to 2.6 M (+11.46 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 167,537 | 0 | 2,355,713 | 2.2 M to 2.4 M (+7.66 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 544,047 | 0 | 2,188,176 | 1.6 M to 2.2 M (+33.09 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 260,617 | 0 | 1,644,129 | 1.4 M to 1.6 M (+18.84 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 312,741 | 0 | 1,383,512 | 1.1 M to 1.4 M (+29.21 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 1,070,771 | 0 | 1,070,771 | 0 to 1.1 M |
| Sep 20 2018 | PRNB | Principia Biopharm ... | AKKARAJU SRINIVAS | Director | Option Exercise | C | 0.00 | 208,480 | 0 | 0 | |
| Sep 20 2018 | PRNB | Principia Biopharm ... | AKKARAJU SRINIVAS | Director | Buy | P | 17.00 | 175,000 | 2,975,000 | 383,480 | 208.5 K to 383.5 K (+83.94 %) |
| Sep 20 2018 | PRNB | Principia Biopharm ... | AKKARAJU SRINIVAS | Director | Buy | C | 0.00 | 208,480 | 0 | 208,480 | 0 to 208.5 K |